Exact Mass: 982.3978471999999

Exact Mass Matches: 982.3978471999999

Found 54 metabolites which its exact mass value is equals to given mass value 982.3978471999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sialyl Lex tetra

(2S,4S,5R,6R)-2-{[(2S,3R,4S,5S,6R)-3,5-dihydroxy-2-{[(2R,3S,4R,5R,6S)-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-{[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl]oxy}-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate

C37H62N2O28 (982.3488932)


Sialyl Lewis X (sLeX) is a tetra-saccharide glycoconjugate of membrane proteins. It acts as a ligand for the selectin proteins during cell adhesion of inflammatory process. Aberrant overexpression of sLeX is also a characteristic of various cancer cells, especially for highly malignant ones. In this paper, the sLeX-specific RNA aptamer was selected using a random RNA library and its affinity and specificity were measured by Surface Plasmon Resonance technique. (PMID: 11178986 ) [HMDB] Sialyl Lewis X (sLeX) is a tetra-saccharide glycoconjugate of membrane proteins. It acts as a ligand for the selectin proteins during cell adhesion of inflammatory process. Aberrant overexpression of sLeX is also a characteristic of various cancer cells, especially for highly malignant ones. In this paper, the sLeX-specific RNA aptamer was selected using a random RNA library and its affinity and specificity were measured by Surface Plasmon Resonance technique. (PMID: 11178986).

   

Sialyl Lea tetra

(2S,4S,5R)-2-{[(2R,3R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,5S,6R)-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-2-{[(2R,3S,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl]oxy}-5-{[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-6-[(2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate

C37H62N2O28 (982.3488932)


Sialyl Lea tetra is a sialylated oligosaccharide normally occurring in human breast milk, with N-acetylglucosamine as the reducing-end residue. Sialylated oligosaccharides are important components of glycoproteins and glycolipids and also occur as free oligosaccharides in several body fluids. In human milk, both free and bound sialylated oligosaccharides have potential biological activity and are known to inhibit viral infection. Sialyl Lewis a is increasingly expressed in melanoma cells, and hypothetically immunotherapy eliciting a humoral response could be therapeutically effective against tumors. (PMID: 9426699, 2318868; 10683228, 1778981) [HMDB] Sialyl Lea tetra is a sialylated oligosaccharide normally occurring in human breast milk, with N-acetylglucosamine as the reducing-end residue. Sialylated oligosaccharides are important components of glycoproteins and glycolipids and also occur as free oligosaccharides in several body fluids. In human milk, both free and bound sialylated oligosaccharides have potential biological activity and are known to inhibit viral infection. Sialyl Lewis a is increasingly expressed in melanoma cells, and hypothetically immunotherapy eliciting a humoral response could be therapeutically effective against tumors. (PMID: 9426699, 2318868; 10683228, 1778981).

   

PIP(16:1(9Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

{[(1R,3S)-3-({[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-{[(5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(16:1(9Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(16:1(9Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)), in particular, consists of one chain of 9Z-hexadecenoyl at the C-1 position and one chain of Lipoxin A5 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:1(9Z))

{[(1R,3S)-3-({[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-{[(5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:1(9Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:1(9Z)), in particular, consists of one chain of Lipoxin A5 at the C-1 position and one chain of 9Z-hexadecenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(16:2(9Z,12Z)/PGE2)

{[(1S,6R,12Z,15R,18R,19S,20R,21R,22R,23S,24R)-6-{[(9Z,12Z)-hexadeca-9,12-dienoyloxy]methyl}-3,18,20,22,23,24-hexahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8,16-trioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracos-12-en-21-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(16:2(9Z,12Z)/PGE2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(16:2(9Z,12Z)/PGE2), in particular, consists of one chain of 9Z,12Z-hexadecenoyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(PGE2/16:2(9Z,12Z))

{[(1S,6R,13Z,16R,19R,20S,21R,22R,23R,24S,25R)-6-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]-3,19,21,23,24,25-hexahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9,17-trioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacos-13-en-22-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(PGE2/16:2(9Z,12Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(PGE2/16:2(9Z,12Z)), in particular, consists of one chain of Prostaglandin E2 at the C-1 position and one chain of 9Z,12Z-hexadecenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(16:2(9Z,12Z)/PGD2)

{[(1S,6R,12Z,15S,16S,19R,20R,21R,22R,23S,24R)-6-{[(9Z,12Z)-hexadeca-9,12-dienoyloxy]methyl}-3,16,20,22,23,24-hexahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8,18-trioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracos-12-en-21-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(16:2(9Z,12Z)/PGD2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(16:2(9Z,12Z)/PGD2), in particular, consists of one chain of 9Z,12Z-hexadecenoyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(PGD2/16:2(9Z,12Z))

{[(1S,6R,13Z,16S,17S,20R,21R,22R,23R,24S,25R)-6-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]-3,17,21,23,24,25-hexahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9,19-trioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacos-13-en-22-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(PGD2/16:2(9Z,12Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(PGD2/16:2(9Z,12Z)), in particular, consists of one chain of Prostaglandin D2 at the C-1 position and one chain of 9Z,12Z-hexadecenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(16:2(9Z,12Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

{[(1R,3S)-3-({[(2R)-3-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]-2-{[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(16:2(9Z,12Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(16:2(9Z,12Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of 9Z,12Z-hexadecenoyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:2(9Z,12Z))

{[(1R,3S)-3-({[(2R)-2-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]-3-{[(5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:2(9Z,12Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:2(9Z,12Z)), in particular, consists of one chain of Lipoxin A4 at the C-1 position and one chain of 9Z,12Z-hexadecenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(18:3(6Z,9Z,12Z)/5-iso PGF2VI)

{[(1S,6R,10Z,13R,14S,16R,17S,18R,19R,20R,21S,22R)-3,14,16,18,20,21,22-heptahydroxy-17-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-6-{[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]methyl}-3,8-dioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[11.6.3]docos-10-en-19-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(18:3(6Z,9Z,12Z)/5-iso PGF2VI) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(18:3(6Z,9Z,12Z)/5-iso PGF2VI), in particular, consists of one chain of 6Z,9Z,12Z-octadecatrienoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(5-iso PGF2VI/18:3(6Z,9Z,12Z))

{[(1S,6R,11Z,14R,15S,17R,18S,19R,20R,21R,22S,23R)-3,15,17,19,21,22,23-heptahydroxy-18-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-6-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-3,9-dioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[12.6.3]tricos-11-en-20-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(5-iso PGF2VI/18:3(6Z,9Z,12Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(5-iso PGF2VI/18:3(6Z,9Z,12Z)), in particular, consists of one chain of 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of 6Z,9Z,12Z-octadecatrienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(18:3(9Z,12Z,15Z)/5-iso PGF2VI)

{[(1S,6R,10Z,13R,14S,16R,17S,18R,19R,20R,21S,22R)-3,14,16,18,20,21,22-heptahydroxy-17-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-6-{[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]methyl}-3,8-dioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[11.6.3]docos-10-en-19-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(18:3(9Z,12Z,15Z)/5-iso PGF2VI) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(18:3(9Z,12Z,15Z)/5-iso PGF2VI), in particular, consists of one chain of 9Z,12Z,15Z-octadecatrienoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(5-iso PGF2VI/18:3(9Z,12Z,15Z))

{[(1S,6R,11Z,14R,15S,17R,18S,19R,20R,21R,22S,23R)-3,15,17,19,21,22,23-heptahydroxy-18-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-6-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]-3,9-dioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[12.6.3]tricos-11-en-20-yl]oxy}phosphonic acid

C45H76O19P2 (982.4455806)


PIP(5-iso PGF2VI/18:3(9Z,12Z,15Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(5-iso PGF2VI/18:3(9Z,12Z,15Z)), in particular, consists of one chain of 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of 9Z,12Z,15Z-octadecatrienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   

26-O-beta-D-glucopyranosyl 22-hydroxy-25(R)-furost-5-en-1beta,3beta,26-triol 1-O-alpha-L-rhamnopyranosyl(1->2)-4-O-sulfo-beta-D-fucopyranoside

26-O-beta-D-glucopyranosyl 22-hydroxy-25(R)-furost-5-en-1beta,3beta,26-triol 1-O-alpha-L-rhamnopyranosyl(1->2)-4-O-sulfo-beta-D-fucopyranoside

C45H74O21S (982.4443074000001)


   

5,7-diacetoxy-2-(5-carboxy-N-methylpyridonyl)-4-hydroxy-1,8,11-triisobutyloyl-oxy-3,15-[2,3-dimethyl-3-(3-carboxy-4-pyridyl)propanoic acid]dicarbolactone-dihydroagarofuran

5,7-diacetoxy-2-(5-carboxy-N-methylpyridonyl)-4-hydroxy-1,8,11-triisobutyloyl-oxy-3,15-[2,3-dimethyl-3-(3-carboxy-4-pyridyl)propanoic acid]dicarbolactone-dihydroagarofuran

C49H62N2O19 (982.3946582000001)


   
   

1,5-diacetoxy-2-(5-carboxy-N-methylpyridonyl)-4-hydroxy-7,8,11-triisobutyloyl-oxy-3,15-[2,3-dimethyl-3-(3-carboxy-4-pyridyl)propanoic acid]dicarbolactone-dihydroagarofuran

1,5-diacetoxy-2-(5-carboxy-N-methylpyridonyl)-4-hydroxy-7,8,11-triisobutyloyl-oxy-3,15-[2,3-dimethyl-3-(3-carboxy-4-pyridyl)propanoic acid]dicarbolactone-dihydroagarofuran

C49H62N2O19 (982.3946582000001)


   
   

Sialyl Lex tetra

O-(N-Acetyl-alpha-neuraminosyl)-(2->3)-O-beta-delta-galactopyranosyl-(1->4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)- D-galactose

C37H62N2O28 (982.3488932)


   

Sialyl Lea tetra

O-(N-Acetyl-alpha-neuraminosyl)-(2->3)-O-beta-delta-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)- D-galactose

C37H62N2O28 (982.3488932)


   
   
   
   
   

PIP(18:3(6Z,9Z,12Z)/5-iso PGF2VI)

PIP(18:3(6Z,9Z,12Z)/5-iso PGF2VI)

C45H76O19P2 (982.4455806)


   

PIP(5-iso PGF2VI/18:3(6Z,9Z,12Z))

PIP(5-iso PGF2VI/18:3(6Z,9Z,12Z))

C45H76O19P2 (982.4455806)


   

PIP(18:3(9Z,12Z,15Z)/5-iso PGF2VI)

PIP(18:3(9Z,12Z,15Z)/5-iso PGF2VI)

C45H76O19P2 (982.4455806)


   

PIP(5-iso PGF2VI/18:3(9Z,12Z,15Z))

PIP(5-iso PGF2VI/18:3(9Z,12Z,15Z))

C45H76O19P2 (982.4455806)


   

PIP(16:1(9Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

PIP(16:1(9Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C45H76O19P2 (982.4455806)


   

PIP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:1(9Z))

PIP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:1(9Z))

C45H76O19P2 (982.4455806)


   

PIP(16:2(9Z,12Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

PIP(16:2(9Z,12Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C45H76O19P2 (982.4455806)


   

PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:2(9Z,12Z))

PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:2(9Z,12Z))

C45H76O19P2 (982.4455806)


   

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal

C37H62N2O28 (982.3488932)


   

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc-(1->2)-alpha-D-Manp

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc-(1->2)-alpha-D-Manp

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Glc

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Glc

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Glc

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Glc

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-4)b-Gal

NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-4)b-Gal

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal

NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-6)Gal

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-6)Gal

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-6)b-Gal

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-6)b-Gal

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)b-Gal

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)b-Gal

C37H62N2O28 (982.3488932)


   

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)a-Gal

NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)a-Gal

C37H62N2O28 (982.3488932)


   

22,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-19,21-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

22,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-19,21-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

C49H62N2O19 (982.3946582000001)


   

[(2r,3s,4s,5r,6r)-4-hydroxy-6-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6-hydroxy-7,9,13-trimethyl-6-[(3r)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-2-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(2r,3s,4s,5r,6r)-4-hydroxy-6-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6-hydroxy-7,9,13-trimethyl-6-[(3r)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-2-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C45H74O21S (982.4443074000001)


   

19,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-21,22-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

19,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-21,22-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

C49H62N2O19 (982.3946582000001)


   

[(2r,3r,4r,5r,6r)-6-{[(1s,2s,4s,6s,7s,8r,9s,12s,13r,14r,16r)-6,16-dihydroxy-7,9,13-trimethyl-6-[(3r)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl]oxy}-4-hydroxy-2-methyl-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(2r,3r,4r,5r,6r)-6-{[(1s,2s,4s,6s,7s,8r,9s,12s,13r,14r,16r)-6,16-dihydroxy-7,9,13-trimethyl-6-[(3r)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl]oxy}-4-hydroxy-2-methyl-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C45H74O21S (982.4443074000001)


   

(6-{[6,16-dihydroxy-7,9,13-trimethyl-6-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl]oxy}-4-hydroxy-2-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl)oxidanesulfonic acid

(6-{[6,16-dihydroxy-7,9,13-trimethyl-6-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl]oxy}-4-hydroxy-2-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl)oxidanesulfonic acid

C45H74O21S (982.4443074000001)


   

(1s,3r,13s,14s,17s,18r,19r,20r,21s,22r,23r,24r,25s)-22,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-19,21-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

(1s,3r,13s,14s,17s,18r,19r,20r,21s,22r,23r,24r,25s)-22,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-19,21-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

C49H62N2O19 (982.3946582000001)


   

(1s,3r,13s,14s,17s,18r,19r,20r,21s,22r,23r,24r,25s)-19,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-21,22-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

(1s,3r,13s,14s,17s,18r,19r,20r,21s,22r,23r,24r,25s)-19,24-bis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-21,22-bis[(2-methylpropanoyl)oxy]-20-{[(2-methylpropanoyl)oxy]methyl}-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

C49H62N2O19 (982.3946582000001)


   

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-n-{1-[({[1-({[(1-{[2-hydroxy-1-({1-[(1-hydroxy-3-oxopropan-2-yl)-c-hydroxycarbonimidoyl]-2-sulfanylethyl}-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]methyl}-c-hydroxycarbonimidoyl)-2-(c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}methyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}butanediimidic acid

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-n-{1-[({[1-({[(1-{[2-hydroxy-1-({1-[(1-hydroxy-3-oxopropan-2-yl)-c-hydroxycarbonimidoyl]-2-sulfanylethyl}-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]methyl}-c-hydroxycarbonimidoyl)-2-(c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}methyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}butanediimidic acid

C40H62N12O15S (982.4178102)